Moderators: John Aruny, MD; Takashi Sato, MD, PhD; Maurizio Gallieni, MD, FASN

• Vascular Access in North America: John Aruny, MD
• Vascular Access in Latin America: Carlos, Hinojosa
• Vascular Access in Japan: Takashi Sato, MD, PhD
• Vascular Access in the United Kingdom: Nicholas Inston, MD
• Vascular Access in Europe: Maurizio Gallieni, MD, FASN
• Panel Discussion: All

Moderators: Haimanot Wasse, MD, MPH; Charles Keith Ozaki, MD

• The Interventional Nephrology Team Approach to AV Access: Haimanot Wasse, MD, MPH
• Team Maturation of the Access and the Surgeon: Charles Keith Ozaki, MD
• Coordinating Teams from Access Creation to the Dialysis Center: Janet Holland, RN, CNN
• Team Approach to AV Access in Japan: Akira Miyata, MD
• Why Radiologists and Surgeons Need to Get Along: Charles Kim, MD, FSIR
• Panel Discussion: All

Moderators: David Cull, MD; Charmaine Lok, MD, FRCPC, MSc

• How I Keep Track of my 10,000 Fistulas: John Lucas III, MD, FACS
• SVS/VQI Data Collection for AV Access: Karen Woo, MD
• What Does a Rand Analysis in AV Access Teach Us? David Cull, MD
• Update on the New KDOQI Guidelines: Charmaine Lok, MD, FRCPC, MSc
• Panel Discussion: All

Moderator: Jeff Lawson, MD, PhD

000018 CREATING ARTERIOVENOUS FISTULAS FOR CHILDREN IN GUATEMALA
Jennings W¹, Lou-Meda R², Mallios A³, Méndez-Soveranis S⁴, Sosa-Tejada R⁵, Lucas III J⁶, Gradman W^7
1The University of Oklahoma College of Medicine, Tulsa, OK, USA
²Fundación para el Niño Enfermo Renal, Guatemala City, Guatemala
³Institut Mutualiste Montsouris, Paris, France
⁴Hospital Roosevelt, Guatemala City, Guatemala
⁵Mariano Galvez University Roosevelt Hospital, Guatemala City, Guatemala
⁶Greenwood Leflore Hospital, Greenwood, MS, USA
⁷Private practice, Beverly Hills, CA, USA

000053 Left ventricular function does not predict all-cause mortality in incident hemodialysis patients
Shintaku S¹, Kawanishi H¹, Moriishi M², Tsuchiya S^1
1Tsuchiya General Hospital, Hiroshima, Japan
²Nkajima Tsuchiya Clinic, Hiroshima, Japan

000051 Comparison of the axillary-atrial versus axillary-iliac arteriovenous grafts for hemodialysis
Lopez G, Anaya-Ayala J, Lizola R, Garcia J, Cuen, C, Hinojosa C
Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

000068 Saturday Multi-Disciplinary Hemodialysis Access Clinics to Enhance Patient Care
Levitsky L, Ruske J, Hentschel D, Nguyen L, Shah S, Ozaki C
Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, USA

000043 Intraoperative Pneumatic Tourniquet Use May Improve the Clinical Outcomes of Arteriovenous Fistula Creations
Wang S
Arizona Kidney Disease and Hypertension Center, Phoenix, AZ, USA

000049 Significance of a protocol based arteriovenous dialysis access site maintenance program
Blessios G¹, Diaz A^2
1Surgical Consulting PLLC, Buffalo, NY, USA
²Catholic Health internal medicine resident, Buffalo, NY, USA

000020 Hemodynamical changes after brachiobasilic arteriovenousfistulas in patients with and without previous ipsilateralvascular access
Zonnebeld N, van Loon M, Tordoir J
Maastricht University Medical Center+, Maastricht, Netherlands


000065 Simple Aneurysmorrhaphy Combined with a Novel Banding Technique Provides Good Short-Term Results
Browne B
Balboa Institute of Transplantation, San Diego, CA, USA

Moderators: Jeff Lawson, MD, PhD; Prabir Roy-Chaudhry, MD, PhD, FRCP (Edin)

• Regulation, Safety and the US FDA: Robert Lee, MD
• How Big Companies Innovate New Products: Mark Ohan, MD
• Disrupting the Vascular Access Space with Start-Ups: Nick Franano, MD
• How CROs Can Help Accelerate the Approval of Drugs & Devices for Dialysis Patients: Barbara Gillespie, MD, MMS, FASN
• KHI Fostering Innovation in Vascular Access Care: Prabir Roy-Chaudhry, MD, PhD, FRCP (Edin)
• The LDO View of Innovation in Vascular Access and Dialysis Care: Frank Maddux, MD
• Panel Discussion: All

Moderators: Stephen Hohmann, MD, FACS; Karl Illig, MD

• AV Graft Outflow Vein Stenosis: Yael Vin, MD, MPH
• The Mega-Overflow Fistula: John Ross, MD
• Steel: Stephen Hohmann, MD, FACS
• Central Vein Obstruction: Charles Kim, MD, FSIR
• Thoracic Inlet Pathology: Karl Illig, MD
• AV Access in the Failing Transplant Patient: David Leeser, MD
• Panel Discussion: All

Moderators: Ingemar Davidson, MD; Aris Urbanes, MD

• Can You Really Teach Surgeons/Nephrologists About Vascular Access? Ingemar Davidson, MD
• What Do Radiologists Need to Know About Vascular Access? Bart Dolmatch, MD
• Teaching the Bigger AV Access Team: Deborah Brouwer-Maier, RN, CNN, FMC
• How Do You Train PAs/NPs to Be Access Providers: Shawn Gage, MD
• How do Interventional Nephrologists Learn Their Craft? Aris. Urbanes, MD
• Panel Discussion: All

Moderators: William Jennings, MD, FACS; Dirk Hentschel, MD

• Fistulas in Challenging Patients - Central Vein Obstruction and Obesity: William Jennings, MD, FACS
• What’s Up with Fistula Side Branch Ligation? Dirk Hentschel, MD
• Percutaneous Fistulas - The NEAT Update: Dheeraj Rajan, BSc, MD, FRCPC
• Percutaneous Fistulas - The Ellipsys Trial: Jeffery Hull, MD
• Proteon - An Update on AV Fistula Maturation: Charles Keith Ozaki, MD
• Panel Discussion: All

Moderators: Marc Glickman, MD; David Kingsmore, MD

• The Evolution of AV Graft Technology: Marc Glickman, MD
• How I Use Early Cannulation Grafts: David Kingsmore, MD
• Does Surface Coating or Flow Modification Alter AV Graft Function: Stephen Hohmann, MD, FACS
• Biologic Vascular Grafts: Marc Glickmann, MD
• HeROs and Hybrids: Stephen Hohmann, MD, FACS
• Panel Discussion: All

Moderator: Deborah Brouwer-Maier RN, CNN, FMC

000057 Endovascular Proximal Forearm Fistula: Early Experience in Birmingham, England
Inston N, Khawaja A, Tullett K, Dutton M, Jones R
Queen Elizabeth Hospitals Birmingham; University Hospitals Birmingham, Birmingham, United Kingdom

000036 Variations in catheter rates are poorly explained by differences In patient characteristics
Blanchard T, Usvyat L, Hymes J, Maddux F
Fresenius Medical Care North America, Waltham, MA, USA

000004 ASSESSMENT OF CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS
Zulkarnaev A, Vatazin A, Fominikh N, Strugailo E, Stepanov V, Yankovoy A
Moscow Regional Research and Clinical Institute, Moscow, Russian Federation

000037 AFE System Rapidly Dilates Ovine Cephalic Veins Before AVF Surgery and Enhances AVF Maturation
Franano F¹, Loree H², Richardson J², Groth D³, Larrabee R⁴, Szenay L⁴, Hutto B⁵,
Dixon B⁶, Shenoy S
¹Flow Forward Medical, Inc., Fairway, KS, USA
²Flow Forward Medical, Inc., Lowell, MA, USA
³Dale Groth Preclinical Consulting, LLC, Forest Lake, MN, USA
⁴Surpass, Inc., Osceola, WI, USA
⁵CIRTEC Medical Corp., Los Gatos, CA, USA
⁶University of Iowa Hospital and Clinics, Iowa City, IA, USA
⁷Washington University in St. Louis School of Medicine, St. Louis, MO, USA

000005 AVF BANDING: AMBIGUOUS CONSEQUENCES
Zulkarnaev A, Vatazin A, Fominikh N, Strugailo E, Stepanov V, Yankovoy A
Moscow Regional Research and Clinical Institute, Moscow, Russian Federation

000073 Is the Carotid Intima-Media Thickness (CIMT) ultrasound assessment a valuable parameter to predict outcomes during hemodialysis access creation?
Torres-Machorro A, Anaya-Ayala J, Garcia-Alva R, Cuen-Ojeda C, Lopez-Mendez A, Luna L,
Lizola-Crespo R, Hinojosa, C
Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, Mexico

000064 Dialysis nurse’s perspective on potential patient benefits from an endovascular arteriovenous fistula (endoAVF)
Tullett K, Khawaja A, Jones R, Inston N
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

Moderator: Jeff Lawson, MD, PhD

• The Real HFM Story...Do Fistulas Mature, When, If and How Often? Prabir Roy-Chaudhury, MD, PhD, FRCP (Edin)
• Panel Discussion: All

Moderators: Jeff Lawson, MD, PhD; Scott Trerotola, MD

• The Laminate VasQ AVF Stent: Mitch Henry, MD
• Vascular Therapies: Siriam Iyer, MD, FACC, FSCAI
• DCB: PTA Version 2.0: Dr. Scott Trerotola, MD
• Tissue Engineered Blood Vessels for Dialysis Access: Jeff Lawson, MD, PhD
• Fist Assist: Tej Singh, MD, MBA
• The Chameleon Technique- New Approaches to Access Maintenance: Jeffrey Hoggard, MD
• Panel Discussion: All

Moderators: Ted Saad, MD; John Aruny, MD; Stephen Hohmann, MD, FACS

• The Best/Worst Case Ever: John Ross, MD
• The Best/Worst Case Ever: Ted Saad, MD
• The Best/Worst Case Ever: John Aruny, MD
• The Best/Worst Case Ever: Bart Dolmatch, MD
• The Best/Worst Case Ever: Stephen Hohmann, MD, FACS
• Panel Discussion - “Lessons Learned from the Mistakes I’ve Made”: All

Moderators: John Ross, MD; Jeff Lawson, MD, PhD

• 40 Years of Doing Dialysis Access - What Have I Learned? John Ross, MD
• Closing Remarks and Future of VASA: Jeff Lawson, MD, PhD